Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced ...
Abstract: This article introduces a fully dynamic SAR-assisted pipeline analog-to-digital converter (ADC) that uses a floating ring amplifier (FLORA) and gain-enhancing Miller negative capacitance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results